Natalizumab throughout pregnancy: Risk of low platelet count in the newborn at delivery

Saved in:

Bibliographic Details
Published in:	Revue neurologique Vol. 172; no. 2; pp. 165 - 166
Main Authors:	Ciron, J., Hautecoeur, P., Mathis, S., Neau, J.-P.
Format:	Journal Article
Language:	English
Published:	France Elsevier Masson SAS 01-02-2016
Subjects:	Adult Delivery, Obstetric Female Humans Infant, Newborn - blood Infant, Newborn, Diseases - blood Infant, Newborn, Diseases - chemically induced Male Multiple Sclerosis, Relapsing-Remitting - drug therapy Natalizumab - therapeutic use Platelet Count Pregnancy Pregnancy Complications - drug therapy Prenatal Exposure Delayed Effects - blood Prenatal Exposure Delayed Effects - chemically induced Risk Factors Thrombocytopenia - blood Thrombocytopenia - chemically induced Thrombocytopenia - congenital
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3
ISSN:	0035-3787
DOI:	10.1016/j.neurol.2015.07.007